With a market capitalization of $24,205,365, InspireMD Inc has a greater market value than only 6.35% of US stocks.
For NSPR, its debt to operating expenses ratio is greater than that reported by only 11.03% of US equities we're observing.
InspireMD Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -50.94%, greater than the shareholder yield of merely 5.69% of stocks in our set.
Stocks that are quantitatively similar to NSPR, based on their financial statements, market capitalization, and price volatility, are FEIM, KVHI, CPIX, CRTO, and JRJC.
NSPR's SEC filings can be seen here. And to visit InspireMD Inc's official web site, go to www.inspiremd.com.
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
Third quarter 2020 revenue returns to pre-COVID-19 levels Management to host investor conference call today, November 9, 2020 at 8:30 a.m. ETTEL AVIV, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR)(“Inspire” or the “Company”), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results for the third quarter ended September 30, 2020.Third Quarter 2020 and recent highlights: * The U.S. Food and Drug Administration (FDA) granted InspireMD approval of its Investigational Device Exemption (IDE) application to initiate a pivotal study of CGuard™ EPS. The company has begun to plan its pivotal study and has retained Dr. Christine ...
InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin acquired 222,223 shares of the stock in a transaction on Friday, October 16th. The stock was purchased at an average cost of $0.45 per share, with a total value of $100,000.35. The transaction was disclosed in a document filed with the SEC, which is available through this link. […]
InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin purchased 222,223 shares of the stock in a transaction that occurred on Friday, October 16th. The shares were purchased at an average price of $0.45 per share, with a total value of $100,000.35. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can […]
InspireMD Inc (NYSEAMERICAN:NSPR) Director Gary S. Roubin purchased 222,223 shares of InspireMD stock in a transaction that occurred on Friday, October 16th. The shares were purchased at an average price of $0.45 per share, for a total transaction of $100,000.35. The transaction was disclosed in a filing with the SEC, which is available through the […]